Larry Robbins's BSX Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 113,096 shares of Boston Scientific Corporation (BSX) worth $4.83 M, representing 0.09% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 1.66 M shares. Largest reduction occurred in Q3 2020, reducing 1.07 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +113,096 | New Buy | 113,096 | $42.68 |
| Q4 2022 | -167,213 | Sold Out | 0 | $0.00 |
| Q3 2022 | -728,183 | Reduce 81.33% | 167,213 | $38.73 |
| Q2 2022 | -489,233 | Reduce 35.33% | 895,396 | $37.27 |
| Q1 2022 | +285,945 | Add 26.03% | 1.38 M | $44.29 |
| Q4 2021 | -964,613 | Reduce 46.75% | 1.1 M | $42.48 |
| Q3 2021 | -259,719 | Reduce 11.18% | 2.06 M | $43.39 |
| Q2 2021 | -874,950 | Reduce 27.36% | 2.32 M | $42.76 |
| Q1 2021 | +495,085 | Add 18.32% | 3.2 M | $38.65 |
| Q4 2020 | +1.66 M | Add 158.64% | 2.7 M | $35.95 |
| Q3 2020 | -1.07 M | Reduce 50.54% | 1.05 M | $38.21 |
| Q2 2020 | -274,858 | Reduce 11.51% | 2.11 M | $35.11 |
| Q1 2020 | +2.39 M | New Buy | 2.39 M | $32.63 |
Larry Robbins's Boston Scientific Corporation Investment FAQs
Larry Robbins first purchased Boston Scientific Corporation (BSX) in Q1 2020, acquiring 2,387,859 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Boston Scientific Corporation (BSX) for 13 quarters since Q1 2020.
Larry Robbins's largest addition to Boston Scientific Corporation (BSX) was in Q1 2020, adding 2,387,859 shares worth $77.92 M.
According to the latest 13F filing for Q2 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 113,096 shares of Boston Scientific Corporation (BSX), valued at approximately $4.83 M.
As of the Q2 2026 filing, Boston Scientific Corporation (BSX) represents approximately 0.09% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Boston Scientific Corporation (BSX) was 3,197,966 shares, as reported at the end of Q1 2021.